Contemporary device management of cardiogenic shock following acute myocardial infarction
Review published in Heart failure reviews (2021)
Abstract
Despite advances in the overall management of acute myocardial infarction (AMI), cardiogenic shock in the setting of AMI (CS-AMI) continues to be associated with poor patient outcomes. There are multiple devices that can be used in CS-AMI to support the failing circulation, although their utility in improving outcomes as compared with conventional pharmacotherapy of vasopressors and inotropes remains to be established. This contemporary review provides an update on the evidence base for each of these techniques. In CS-AMI, acute thrombotic occlusion of a major epicardial artery leads to hypoxia and myocardial ischaemia in the territory subtended by that vessel. The resultant regional dysfunction in myocardial contractility can severely compromise stroke volume and result in acute circulatory failure, systemic hypoperfusion, lactic acidosis, multi-organ failure and ultimately death.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Despite advances in the overall management of acute myocardial infarction (AMI), cardiogenic shock in the setting of AMI (CS-AMI) continues to be associated with poor patient outcomes.
Por qué esto importa para la hirudoterapia
This review provides an update on the evidence base for multiple devices used to support the failing circulation in cardiogenic shock complicating acute myocardial infarction (CS-AMI), comparing their utility against conventional pharmacotherapy of vasopressors and inotropes. The abstract describes the pathophysiology of CS-AMI, noting that acute thrombotic occlusion of a major epicardial artery can lead to circulatory failure, systemic hypoperfusion, lactic acidosis, multi-organ failure, and death, and that outcomes remain poor despite advances in management. This review makes no mention of leeches, hirudin, leech therapy, or the leech secretome. Caveat: it has no identifiable relevance to hirudotherapy or ASH's domain.
Citación
Contemporary device management of cardiogenic shock following acute myocardial infarction
Suleiman T et al. · Heart failure reviews, 2021
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026